Bone Stimulation Therapy: How It Works and Who Needs It

Bone stimulation therapy uses electrical signals or ultrasound waves to encourage bone healing in fractures or surgical sites that aren’t mending on their own. It’s most commonly prescribed for nonunion fractures (breaks that have stalled for three or more months without progress) and as a supplement to spinal fusion surgery. The therapy works by mimicking or amplifying the natural electrical and mechanical signals your body uses to build new bone tissue.

How Bone Stimulation Works

Your bones naturally generate small electrical charges when they’re under stress or healing from injury. These signals recruit bone-building cells to the site and trigger the release of proteins that drive new bone formation, including members of the TGF-beta family, which are critical regulators of bone growth and repair. Bone stimulation therapy amplifies this process artificially, delivering energy to the fracture site from outside or inside the body.

The added energy nudges stem cells in the bone marrow to mature into active bone-building cells and ramps up production of the signaling proteins that coordinate repair. Think of it as turning up the volume on a signal your body is already sending, but too quietly to finish the job.

Types of Bone Stimulators

Electrical Stimulators

There are three main electrical approaches, and they differ primarily in how the current reaches the bone.

  • Direct current (implanted): A small device is surgically placed at the fracture or fusion site and delivers a steady electrical current directly to the bone. Because it’s internal, you don’t need to do anything once it’s implanted, but it does require a surgical procedure.
  • Capacitive coupling: Two metal electrodes are placed on the skin on opposite sides of the fracture. A low-level current passes between them through the tissue. Some capacitive coupling devices are designed to be worn up to 24 hours a day.
  • Pulsed electromagnetic field (PEMF): A pair of magnetic coils sit outside the body, often on top of a cast, and generate pulsing electromagnetic fields that penetrate to the bone. These are the most common noninvasive type. Daily wear time varies by device, from 30 minutes to about 3 hours per session.

Ultrasound Stimulators

Low-intensity pulsed ultrasound (LIPUS) takes a different approach entirely. Instead of electrical energy, it sends mechanical sound waves through the skin at very low power levels, typically around 30 milliwatts per square centimeter. The sound waves create tiny vibrations at the fracture site that stimulate bone cells. LIPUS devices usually require about 20 minutes of daily use and are placed directly on the skin over the fracture.

One consideration with ultrasound is that the signal weakens as it passes through soft tissue. In deep fractures like those in the hip, the effective intensity at the bone can drop significantly, which is why frequency and positioning matter for treatment effectiveness.

When Bone Stimulation Is Prescribed

The FDA has cleared bone growth stimulators for several specific situations:

  • Nonunion fractures: Breaks that have stopped healing, confirmed by X-rays taken at least 90 days apart showing no progress.
  • Failed fusions: Previous surgical attempts to fuse bones that didn’t take.
  • Spinal fusion support: As an add-on therapy after lumbar or cervical spinal fusion surgery to improve the odds of solid bone growth.
  • Congenital pseudarthrosis: A rare condition where bone fails to form properly from birth.
  • Certain fresh fractures: Some devices are cleared for early use on specific types of new fractures considered at high risk for healing problems.

For spinal fusion patients, the stimulator is typically started shortly after surgery. Surgeons often recommend using the device until the battery dies, which is usually 6 to 9 months, covering the critical window when the fusion is solidifying.

How Effective Is It?

For nonunion fractures treated with ultrasound stimulation, studies reviewed by the Centers for Medicare and Medicaid Services found overall healing rates between 80% and 100% across multiple trials. When researchers used stricter “intention to treat” analysis, which counts every patient who started treatment regardless of whether they completed it, the rates ranged from 64% to 93%. A large registry of over 1,500 nonunion fractures treated with ultrasound stimulation showed an 83% healing rate.

These numbers are comparable to surgical treatment of nonunions, which historically succeeds in 68% to 96% of cases. The advantage of noninvasive stimulation is that it avoids the risks and recovery time of another surgery, making it a reasonable first option for many patients before considering a repeat operation.

What Daily Treatment Looks Like

If you’re prescribed a noninvasive bone stimulator, your daily routine will depend on the specific device. Electromagnetic stimulators range widely: some require just 30 minutes a day, while others call for around 3 hours. Capacitive coupling devices can be worn throughout the day and night. Ultrasound devices typically need about 20 minutes of daily application with a gel coupling pad on the skin.

Consistency matters more than anything else. Missing sessions reduces the cumulative stimulation your bone receives and can compromise results. Most treatment courses last several months. Your doctor will order periodic X-rays to track whether new bone is forming at the site.

Insurance Coverage Requirements

Medicare and most private insurers cover bone stimulators, but only when specific criteria are met. For nonunion fractures, coverage requires documentation that healing has stalled for at least 3 months. This must be confirmed by at least two sets of X-rays taken 90 or more days apart, each with multiple views of the fracture, and a physician’s written interpretation stating there’s been no meaningful healing progress between the two sets.

These requirements exist because bone stimulators are not intended for routine fractures that are healing normally, even if slowly. The documentation process can feel bureaucratic, but it’s worth gathering early if your fracture isn’t progressing. Your orthopedic surgeon’s office typically handles the prior authorization paperwork.

Safety and Contraindications

Noninvasive bone stimulators carry minimal risk for most people, since they deliver very low levels of energy. However, there are important exceptions.

If you have a demand-type pacemaker or an implantable defibrillator, electromagnetic bone stimulators can interfere with your cardiac device and should not be used. The magnetic fields generated by PEMF devices can disrupt the sensing functions these implants rely on.

Bone stimulators have not been studied in pregnant women, and the effects on a developing fetus are unknown. If pregnancy occurs during treatment, the device should be stopped immediately. The devices are also not established as safe for individuals who haven’t reached skeletal maturity, meaning they’re generally not used in children and adolescents whose bones are still growing.

Several other conditions lack safety data for bone stimulation, including Paget’s disease, severe osteoporosis, metastatic cancer, renal disease, and uncontrolled diabetes. If you have any of these, your doctor will weigh the potential benefit against the uncertainty. Patients with metal hardware at the treatment site should also discuss this with their surgeon, as instrumentation can distort electromagnetic fields and potentially reduce treatment effectiveness.